Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response.
Fiorella D'Auria; Francesco La Rocca; Vittorio Simeon; Teodora Statuto; Giuseppe Pietrantuono; Giovanni D'Arena; Oreste Villani; Giovanna Mansueto; Antonio Traficante; Pellegrino Musto
Author Information: Laboratory of Clinical Research and Advanced Diagnostics, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.; Laboratory of Clinical Research and Advanced Diagnostics, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.; Laboratory of Preclinical and Translational Research, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.; Laboratory of Clinical Research and Advanced Diagnostics, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.; Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.; Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.; Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.; Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.; Unit of Clinical Pathology, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.; Scientific Direction, IRCCS-CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (Pz), Italy.
Checking for direct PDF access through Ovid |
Abstract
Abstract unavailable for this article.